Filing Details

Accession Number:
0001562180-21-002540
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-04-01 20:32:16
Reporting Period:
2021-04-01
Accepted Time:
2021-04-01 20:32:16
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1517022 Akebia Therapeutics Inc. AKBA Pharmaceutical Preparations (2834) 208756903
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591467 P. John Butler C/o Akebia Therapeutics, Inc.
245 First Street
Cambridge MA 02142
Ceo And President No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-04-01 4,109 $3.40 1,152,153 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 59,928 Indirect Held by John Butler 2019 GRAT
Common Stock 100,000 Indirect Held By John Butler GRAT November 2019
Common Stock 31,047 Indirect Held by John Butler Revocable Trust 2007
Common Stock 59,928 Indirect Held by Dorothy Butler 2019 GRAT
Common Stock 100,000 Indirect Held By Dorothy Butler GRAT November 2019
Common Stock 31,047 Indirect Held by Dorothy Butler Revocable Trust 2007
Footnotes
  1. This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one third of the performance-based restricted stock units that were previously reported for the Reporting Person on a Form 4 filed on March 18, 2021.